Industry
Consumers would like to be more informed on the labelling and in communications about probiotic food, and about probiotic microorganisms in food and food supplements.
Collaboration joins MD Anderson's expertise and capabilities with Fed Bio's proprietary ACT bacterial cell therapy platform to design and manufacture a complex, synthetic microbiome-based therapy
Leigh Frame, Director, Integrative Medicine, GW School of Medicine & Health Sciences in Washington, discussed how to exploit metabolomic and genomic data to identify diet-specific signatures.
According to Christoph Lacroix (ETH Zurich), bifidobacteria are critical in the development of the neonatal microbiota. Here's why.
Savita Bernal, Chief Business Officer at MaaT Pharma, discussed the Phase 3 trial (ARES) in patients with acute Graft-versus-Host-Disease with gastrointestinal involvement.
Christine Moissl-Eichinger (Medical University of Graz, Austria) explains the changes in the microbiome of astronauts.
The agreement will aid in the understanding of the microbiome in human disease.
The DGCCRF has announced that the use of the word “probiotic” can be allowed on the label of dietary supplements, as well as the health claim “contributes to the balance…
Fabio Grassi, Founder at MV BioTherapeutics SA, discussed how to understand the mechanisms of action for microbiome contributions to cancer therapeutic response in patients.
First patient to be administered Oncobax® AK, a live bacterial product based on a specific strain found in the gut microbiota, at Institut de Cancérologie Strasbourg Europe (ICANS) in Strasbourg,…
